Sign up to save your podcasts
Or
Share Novel Once-Weekly Basal Insulins: Expert Interpretation of Latest Clinical Data
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Novel Once-Weekly Basal Insulins: Expert Interpretation of Latest Clinical Data
Newer oral glucose-lowering agents have revolutionized the treatment of type 2 diabetes (T2D), yet up to 40% of people across the globe still require insulin.
Credit available for this activity expires: 10/18/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/982624?src=mkm_podcast_series_982624
View all episodes
By Medscape
4.3
2525 ratings
Newer oral glucose-lowering agents have revolutionized the treatment of type 2 diabetes (T2D), yet up to 40% of people across the globe still require insulin.
Credit available for this activity expires: 10/18/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/982624?src=mkm_podcast_series_982624
More shows like Keeping Current CME
View all
JAMA Editors' Summary
136 Listeners
AFP: American Family Physician Podcast
696 Listeners
JAMA Clinical Reviews
497 Listeners
JACC This Week
169 Listeners
Diabetes Core Update
105 Listeners
This Week in Cardiology
883 Listeners
The Bob Harrington Show
14 Listeners
One-on-One with Eric Topol
16 Listeners
Mayo Clinic Talks
296 Listeners
Frankly Speaking About Family Medicine
260 Listeners
The Curbsiders Internal Medicine Podcast
3,346 Listeners
Core IM | Internal Medicine Podcast
1,147 Listeners
Annals On Call Podcast
193 Listeners
JAMA Medical News
94 Listeners
The Clinical Problem Solvers
514 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Freely Filtered, a NephJC Podcast
171 Listeners
Medicine and the Machine
60 Listeners
Keeping Current
8 Listeners
Cardionerds: A Cardiology Podcast
428 Listeners